Skip to main content
NCBI home page
British Medical Journal (Clinical Research Ed.) logoLink to British Medical Journal (Clinical Research Ed.)
. 1988 Jan 16;296(6616):150–151. doi: 10.1136/bmj.296.6616.150

Tardive dyskinesia

Thomas R E Barnes
PMCID: PMC2544889  PMID: 2892565

Full text

PDF
150

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barnes T. R., Braude W. M. Akathisia variants and tardive dyskinesia. Arch Gen Psychiatry. 1985 Sep;42(9):874–878. doi: 10.1001/archpsyc.1985.01790320042006. [DOI] [PubMed] [Google Scholar]
  2. Barnes T. R., Kidger T., Gore S. M. Tardive dyskinesia: a 3-year follow-up study. Psychol Med. 1983 Feb;13(1):71–81. doi: 10.1017/s003329170005008x. [DOI] [PubMed] [Google Scholar]
  3. Barrow N., Childs A. An anti-tardive-dyskinesia effect of verapamil. Am J Psychiatry. 1986 Nov;143(11):1485–1485. doi: 10.1176/ajp.143.11.1485a. [DOI] [PubMed] [Google Scholar]
  4. Davis K. L., Berger P. A., Hollister L. E. Tardive dyskinesia and depressive illness. Psychopharmacol Commun. 1976;2(2):125–130. [PubMed] [Google Scholar]
  5. Gardos G., Cole J. O. Tardive dyskinesia and anticholinergic drugs. Am J Psychiatry. 1983 Feb;140(2):200–202. doi: 10.1176/ajp.140.2.200. [DOI] [PubMed] [Google Scholar]
  6. Goldman M. B., Luchins D. J. Intermittent neuroleptic therapy and tardive dyskinesia: a literature review. Hosp Community Psychiatry. 1984 Dec;35(12):1215–1219. doi: 10.1176/ps.35.12.1215. [DOI] [PubMed] [Google Scholar]
  7. Jeste D. V., Wyatt R. J. Dogma disputed: is tardive dyskinesia due to postsynaptic dopamine receptor supersensitivity? J Clin Psychiatry. 1981 Dec;42(12):455–457. [PubMed] [Google Scholar]
  8. Kane J. M., Smith J. M. Tardive dyskinesia: prevalence and risk factors, 1959 to 1979. Arch Gen Psychiatry. 1982 Apr;39(4):473–481. doi: 10.1001/archpsyc.1982.04290040069010. [DOI] [PubMed] [Google Scholar]
  9. Klawans H. L., Goetz C. G., Perlik S. Tardive dyskinesia: review and update. Am J Psychiatry. 1980 Aug;137(8):900–908. doi: 10.1176/ajp.137.8.900. [DOI] [PubMed] [Google Scholar]
  10. Lohr J. B., Cadet J. L., Lohr M. A., Jeste D. V., Wyatt R. J. Alpha-tocopherol in tardive dyskinesia. Lancet. 1987 Apr 18;1(8538):913–914. doi: 10.1016/s0140-6736(87)92878-9. [DOI] [PubMed] [Google Scholar]
  11. Morgenstern H., Glazer W. M., Gibowski L. D., Holmberg S. Predictors of tardive dyskinesia: results of a cross-sectional study in an outpatient population. J Chronic Dis. 1987;40(4):319–327. doi: 10.1016/0021-9681(87)90047-6. [DOI] [PubMed] [Google Scholar]
  12. Mukherjee S., Rosen A. M., Caracci G., Shukla S. Persistent tardive dyskinesia in bipolar patients. Arch Gen Psychiatry. 1986 Apr;43(4):342–346. doi: 10.1001/archpsyc.1986.01800040052008. [DOI] [PubMed] [Google Scholar]
  13. Ross J. L., Mackenzie T. B., Hanson D. R., Charles C. R. Diltiazem for tardive dyskinesia. Lancet. 1987 Jan 31;1(8527):268–268. doi: 10.1016/s0140-6736(87)90080-8. [DOI] [PubMed] [Google Scholar]
  14. STOLZE R., ULE G. Die Bedeutung der Trigeminusdegeneration für die Sprachstörung bei der hereditären Ataxie. Nervenarzt. 1957 Jan 20;28(1):35–36. [PubMed] [Google Scholar]
  15. Smith J. M., Baldessarini R. J. Changes in prevalence, severity, and recovery in tardive dyskinesia with age. Arch Gen Psychiatry. 1980 Dec;37(12):1368–1373. doi: 10.1001/archpsyc.1980.01780250054006. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal (Clinical research ed.) are provided here courtesy of BMJ Publishing Group

RESOURCES